Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis

Nat Commun. 2021 Sep 1;12(1):5214. doi: 10.1038/s41467-021-25457-y.

Abstract

Dyslipidemia and resulting lipotoxicity are pathologic signatures of metabolic syndrome and type 2 diabetes. Excess lipid causes cell dysfunction and induces cell death through pleiotropic mechanisms that link to oxidative stress. However, pathways that regulate the response to metabolic stress are not well understood. Herein, we show that disruption of the box H/ACA SNORA73 small nucleolar RNAs encoded within the small nucleolar RNA hosting gene 3 (Snhg3) causes resistance to lipid-induced cell death and general oxidative stress in cultured cells. This protection from metabolic stress is associated with broad reprogramming of oxidative metabolism that is dependent on the mammalian target of rapamycin signaling axis. Furthermore, we show that knockdown of SNORA73 in vivo protects against hepatic steatosis and lipid-induced oxidative stress and inflammation. Our findings demonstrate a role for SNORA73 in the regulation of metabolism and lipotoxicity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • CHO Cells
  • Cell Death / drug effects
  • Cricetulus
  • Diabetes Mellitus, Type 2 / metabolism
  • Fatty Liver / drug therapy*
  • Fatty Liver / genetics
  • Fatty Liver / metabolism*
  • Homeostasis
  • Inflammation
  • Lipid Metabolism
  • Lipids / pharmacology
  • Male
  • Metabolic Syndrome / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Oxidative Stress / drug effects
  • Protective Agents / pharmacology*
  • RNA, Long Noncoding
  • RNA, Small Nucleolar / genetics
  • RNA, Small Nucleolar / metabolism*
  • Signal Transduction / drug effects

Substances

  • Lipids
  • Protective Agents
  • RNA, Long Noncoding
  • RNA, Small Nucleolar